DLX3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-88802
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of human DLX3. Peptide sequence: SSILTDISSSLSCHAGSKDSPTLPESSVTDLGYYSAPQHDYYSGQPYGQT The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for DLX3 Antibody
Western Blot: DLX3 Antibody [NBP2-88802]
Western Blot: DLX3 Antibody [NBP2-88802] - WB Suggested Anti-DLX3 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Transfected 293TImmunohistochemistry: DLX3 Antibody [NBP2-88802]
Immunohistochemistry: DLX3 Antibody [NBP2-88802] - PlacentaImmunohistochemistry: DLX3 Antibody [NBP2-88802]
Immunohistochemistry: DLX3 Antibody [NBP2-88802] - Paraffin Embedded Tissue: Human Kidney. Cellular Data: Epithelial cells of renal tubule. Antibody Concentration: 4.0-8.0 ug/ml. Magnification: 400XApplications for DLX3 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: DLX3
Long Name
Homeobox protein DLX-3
Alternate Names
AI4, distal-less homeo box 3, distal-less homeobox 3, homeobox protein DLX-3, TDO
Gene Symbol
DLX3
Additional DLX3 Products
Product Specific Notices for DLX3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...